InnoLaser announced that the company's stocks have experienced a cumulative price increase deviation of over 30% for three consecutive trading days, which constitutes an abnormal fluctuation in stock trading. After verification by the board of directors, it was stated that there are no corrections or supplements needed for previously disclosed information, and no recent public media reports have highlighted other information related to the company that has garnered significant market attention. Currently, the company's operation is normal, and there has been no significant change in the internal and external operating environment. There are no significant matters regarding the company that should be disclosed but have not been disclosed by the company, its controlling shareholder, or actual controller, nor are there any significant matters in the planning stage. The company previously disclosed a pre-announcement of shareholding reductions by shareholders, and the reduction plan is still in the waiting period. The company does not violate fair information disclosure.